TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -358.81%-38.07M | ---- | -30.69%14.71M | ---- | 118.75%21.22M | ---- | -315.73%-113.19M | ---- | 157.43%52.47M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 40.90%-981K | ---- | -48.88%-1.66M | ---- | -982.52%-1.12M | ---- | 57.96%-103K | ---- | -0.82%-245K |
Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.64%-4.86M | ---- | 1.94%-26.49M |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%1K |
Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --340K | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --340K | ---- | ---- |
Revaluation surplus: | ---- | 3,143.59%44.62M | ---- | 71.30%-1.47M | ---- | -104.18%-5.11M | ---- | 473.42%122.14M | ---- | -129.48%-32.71M |
-Fair value of investment properties (increase) | ---- | 3,073.33%44.6M | ---- | 70.59%-1.5M | ---- | -104.00%-5.1M | ---- | 83.84%-2.5M | ---- | ---15.47M |
-Other fair value changes | ---- | -44.12%19K | ---- | 525.00%34K | ---- | -100.01%-8K | ---- | 823.04%124.64M | ---- | -115.53%-17.24M |
Depreciation and amortization: | ---- | -7.14%13K | ---- | 0.00%14K | ---- | 16.67%14K | ---- | -33.33%12K | ---- | -70.49%18K |
Financial expense | ---- | 124.32%7.63M | ---- | 674.49%3.4M | ---- | 3.29%439K | ---- | -85.91%425K | ---- | -8.41%3.02M |
Operating profit before the change of operating capital | ---- | -11.92%13.21M | ---- | -2.94%15M | ---- | 224.96%15.45M | ---- | 220.62%4.76M | ---- | 8.33%-3.94M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 240.95%1.3M | ---- | -46,050.00%-923K | ---- | -104.26%-2K | ---- | --47K | ---- | ---- |
Accounts payable increase (decrease) | ---- | 63.68%-73K | ---- | -104.01%-201K | ---- | -97.96%5.01M | ---- | 680,697.22%245.09M | ---- | -81.35%36K |
prepayments (increase)decrease | ---- | -113.71%-171K | ---- | 205.68%1.25M | ---- | 49.83%-1.18M | ---- | -7,250.00%-2.35M | ---- | -158.18%-32K |
Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 852.10%63.58M |
Cash from business operations | ---- | -5.64%14.27M | ---- | -21.58%15.12M | ---- | -92.21%19.28M | ---- | 315.03%247.54M | ---- | 2,171.25%59.64M |
Hong Kong profits tax paid | ---- | -111.86%-2.06M | ---- | 39.56%-970K | ---- | -306.33%-1.61M | ---- | ---395K | ---- | ---- |
Dividend received - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -81.64%4.86M | ---- | -1.94%26.49M |
Special items of business | -891.52%-138.68M | ---- | 49.83%17.52M | ---- | -87.99%11.69M | ---- | 8,739.75%97.37M | ---- | -117.38%-1.13M | ---- |
Net cash from operations | -891.52%-138.68M | -13.70%12.21M | 49.83%17.52M | -19.94%14.15M | -87.99%11.69M | -92.99%17.68M | 8,739.75%97.37M | 192.56%252.01M | -117.38%-1.13M | 190.58%86.14M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | -40.90%981K | ---- | 48.88%1.66M | ---- | 376.50%1.12M | ---- | -14.29%234K | ---- | 162.50%273K |
Purchase of fixed assets | ---- | -42.86%-10K | ---- | 36.36%-7K | ---- | ---11K | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.83M | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.91M | ---- | ---- |
Other items in the investment business | -86.20%98K | ---- | 477.24%710K | ---- | 925.00%123K | ---- | -94.42%12K | ---- | 152.94%215K | ---- |
Net cash from investment operations | -86.20%98K | -41.26%971K | 477.24%710K | 49.73%1.65M | 925.00%123K | 242.86%1.1M | -94.42%12K | 17.95%322K | 152.94%215K | 53.37%273K |
Net cash before financing | -860.16%-138.59M | -16.58%13.18M | 54.28%18.23M | -15.85%15.8M | -87.87%11.82M | -92.56%18.78M | 10,777.85%97.38M | 192.01%252.33M | -113.89%-912K | 189.76%86.41M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | ---- | ---- | --150M | ---- | ---- | ---- | -472.39%-84.58M |
Refund | ---- | -33.79%-217.1M | ---- | ---162.27M | ---- | ---- | ---- | ---291.41M | ---- | ---- |
Interest paid - financing | ---- | -131.26%-7.4M | ---- | -628.70%-3.2M | ---- | 5.39%-439K | ---- | 85.08%-464K | ---- | 3.15%-3.11M |
Dividends paid - financing | ---- | 28.58%-7.41M | ---- | 10.97%-10.37M | ---- | ---11.65M | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---148.64M | ---- | ---- | ---- | ---- |
Other items of the financing business | -30.68%-12.23M | 25.35%203.94M | -7.81%-9.36M | 10,526.71%162.7M | -17.30%-8.68M | --1.53M | 84.59%-7.4M | ---- | 55.23%-48.01M | ---- |
Net cash from financing operations | -30.68%-12.23M | -112.72%-27.96M | -7.81%-9.36M | -42.99%-13.15M | -17.30%-8.68M | 96.85%-9.19M | 84.59%-7.4M | -232.84%-291.87M | 55.23%-48.01M | -549.66%-87.69M |
Effect of rate | ---186K | -121.74%-10K | ---- | -87.73%46K | ---- | 216.82%375K | ---- | ---321K | ---- | ---- |
Net Cash | -1,799.28%-150.81M | -656.02%-14.78M | 182.73%8.88M | -72.27%2.66M | -96.51%3.14M | 124.24%9.59M | 283.93%89.98M | -2,984.56%-39.54M | 51.40%-48.92M | -102.60%-1.28M |
Begining period cash | -8.51%158.99M | 1.58%173.78M | 1.58%173.78M | 6.18%171.08M | 6.18%171.08M | -19.84%161.12M | -19.84%161.12M | -0.63%200.98M | -0.63%200.98M | 32.25%202.26M |
Cash at the end | -95.62%8M | -8.51%158.99M | 4.84%182.66M | 1.58%173.78M | -30.62%174.22M | 6.18%171.08M | 65.14%251.1M | -19.84%161.12M | 49.66%152.06M | -0.63%200.98M |
Cash balance analysis | ||||||||||
Cash and bank balance | -17.50%8M | -18.13%8.02M | -20.41%9.69M | 17.38%9.79M | -22.58%12.18M | -21.38%8.34M | 664.56%15.73M | 981.65%10.61M | 28.56%2.06M | -56.65%981K |
Cash and cash equivalent balance | -17.50%8M | -18.13%8.02M | -20.41%9.69M | 17.38%9.79M | -22.58%12.18M | -21.38%8.34M | 664.56%15.73M | 981.65%10.61M | 28.56%2.06M | -99.51%981K |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.